National Cancer Centre, Singapore
Clinical trials sponsored by National Cancer Centre, Singapore, explained in plain language.
-
New drug hope for rare throat and thyroid cancers
Disease control Not yet recruitingThis study tests a drug called sacituzumab tirumotecan in people with two rare cancers: adenoid cystic carcinoma (a type of salivary gland cancer) and papillary thyroid carcinoma that have returned or spread. About 68 participants will receive the drug through an IV twice a month…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Acupuncture with a jolt: new trial tests electric needles for cancer brain fog
Symptom relief Not yet recruitingThis Phase 3 trial tests whether electroacupuncture—thin needles with mild electric pulses—can ease cognitive problems like memory loss and trouble focusing in cancer survivors. 168 participants will be assigned to real electroacupuncture, sham (fake) acupuncture, or a waitlist. …
Phase: PHASE3 • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Smell your way to calm: aromatherapy trial for dementia
Symptom relief Not yet recruitingThis study tests whether using a special blend of essential oils at home can improve mood and behavior in people with mild cognitive impairment or early dementia. It also looks at whether this simple, pleasant treatment can reduce stress for their caregivers. Two hundred patients…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Lifestyle tweaks may cut liver cancer risk, new study hints
Knowledge-focused Not yet recruitingThis study looks at whether lifestyle changes can reduce the risk of liver cancer in people already at high risk. Researchers will track changes in bile acids, gut bacteria, and liver health in 90 adults aged 50-90. The goal is to see if simple adjustments can make a lasting diff…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC